RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
| Autor: | M. Basaras, Ramón Cisterna, Maria Carmen Nieto, Daniel Andía, Nerea Fontecha |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Adult High-risk HPV Uterine Cervical Neoplasms Biology Sensitivity and Specificity Specimen Handling Lesion 03 medical and health sciences Young Adult 0302 clinical medicine Virology medicine Humans Papillomaviridae Cervical cancer biomarker Early Detection of Cancer Cervical cancer Oncogene Proteins Messenger RNA Cervical screening Oncogene Research Papillomavirus Infections RNA Oncogenes Middle Aged medicine.disease biology.organism_classification Molecular biology 030104 developmental biology Infectious Diseases 030220 oncology & carcinogenesis RNA Viral Female RNA extraction E6/E7 mRNA medicine.symptom RNA extraction methods |
| Zdroj: | Virology Journal |
| ISSN: | 1743-422X |
| Popis: | Background Human papillomavirus (HPV) DNA testing plays a main role in the management of cervical cancer, however to improve the specificity in cervical screening, there is a need to develop and validate different approaches that can identify women at risk for progressive disease. Nowadays, mRNA expression of viral E6 and E7 HPV oncogenes stands up as a potential biomarker to improve cervical screening. We aimed to validate a method for RNA extraction, detect HPV mRNA expression and, assess the relationship between E6/E7 mRNA expression and pathology of patients’ lesions and progression. Methods This study included 50 specimens that had been previously genotyped as HPV16, 18, 31, 33 and/or 45. Cervical swabs were extracted with three different RNA extraction methods -Nuclisens manual extraction kit (bioMérieux), High Pure Viral RNA Kit (Roche) and RNeasy Plus Mini kit (Qiagen)-, and mRNA was detected with NucliSens EasyQ HPV version 1 test (bioMérieux) afterwards. Association of oncogene expression with pathology and lesion progression was analyzed for each extraction method. Results E6/E7 mRNA positivity rate was higher in samples analyzed with bioMérieux (62%), followed by Roche (24%) and Qiagen (6%). Women with lesions and lesion progression showed a higher prevalence of viral RNA expression than women that had not lesions or with lesion persistence. While bioMérieux revealed a higher sensitivity (77.27%), Roche presented a higher PPV (75%) and an increased specificity (89.28%). Conclusions Extraction methods based on magnetic beads provided better RNA yield than those based in columns. Both Nuclisens manual extraction kit (bioMérieux) and High Pure Viral RNA Kit (Roche) seemed to be adequate for E6/E7 mRNA detection. However, none of them revealed both high sensitivity and specificity values. Further studies are needed to obtain and validate a standard gold method for RNA expression detection, to be included as part of the routine cervical screening program. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink